SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001354488-15-003991
Filing Date
2015-08-19
Accepted
2015-08-19 15:36:55
Documents
4
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDED QUARTERLY REPORT ptx_10qa.htm 10-Q/A 56523
2 ASSET PURCHASE AGREEMENT ptx_ex.htm EX-2.1 840742
3 CERTIFICATION ptx_ex313.htm EX-31.3 6339
4 CERTIFICATION ptx_ex314.htm EX-31.4 5483
  Complete submission text file 0001354488-15-003991.txt   910229
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-14494 | Film No.: 151063924
SIC: 2834 Pharmaceutical Preparations